Thomas Cahill
Signal active
Co-Founder and Managing Partner
Bio
Thomas Cahill is a Co-Founder and Managing Partner of Newpath Partners.
Location
N/A
Social
N/A
Primary Organization
Newpath Management
Founded
2018
Investment
17
Lead investment
7
Exits
2
Employees
1-10
Industry
Jobs history
6
Autobahn Therapeutics
Board Member
Invalid date - Current
Magnet Biomedicine
Board of Directors
2023 - Current
Newpath Management
Co-Founder and Managing Partner
Invalid date - Current
Chroma Medicine
Board Member
Invalid date - Current
Exo Therapeutics
Board Member
Invalid date - Current
Kojin Therapeutics
Board Member
Invalid date - Current
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
Thomas Cahill is the Co-Founder and Managing Partner at Newpath Management, based in United States, North America. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Investment portfolio
N/A
Number of investment
1
Number of exits
0
Personal investment
0
There is no personal investment available on this profile
Partner investment
6
| Annouced Date | Organization Name | Funding Round | Investor Name | Money Raised |
|---|---|---|---|---|
| Oct 05, 2021 | Exo Therapeutics | Series B - Exo Therapeutics | Newpath Management | 78.0M |
| May 18, 2023 | Myeloid Therapeutics | Series A - Myeloid Therapeutics | Newpath Management | 73.0M |
| Sep 19, 2023 | Magnet Biomedicine | Series A - Magnet Biomedicine | Newpath Management | 50.0M |
| Jul 24, 2024 | Autobahn Therapeutics | Series C - Autobahn Therapeutics | Newpath Management | 100.0M |
Exits
0
There is no exit available on this Profile
Invest in industries
N/A
Recent Activity
There is no recent news or activity for this profile.